Rheumatoid Arthritis Patients in Remission Withdrawing from

New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued TNFi.

Related Keywords

California , United States , Oslo , Norway , San Diego , Siri Lillegraven , South Eastern Norway Regional Health Authority , American College Of Rheumatology , European Alliance For Associations , Research Council Of Norway , American College , European Alliance , Diakonhjemmet Hospital , Research Council , South Eastern Norway Regional Health , Withdrawal Compared , Among Rheumatoid Arthritis Patients , Sustained Remission , Multicenter Randomized Trial , Accessed November , Increases Flares , Lowers Boolean Remission Rates , Racr , Rheumatology , Arthritis , Flares , Kntnf ,